Erich von Baumbach (#607)
- $ 7 B
- Pharma
- Germany
- M
- 55 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Erich von Baumbach derives his wealth from Germany's Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. An heir to the fortune, he traces his lineage to the company's founder Albert Boehringer, who founded the company in 1885. After purchasing a tartar factory, Boehringer employed 28 people, who produced ingredients for pharmacies, textile merchants and the food industry. In 1917 the company opened a research department with chemist Heinrich Wieland, Boehringer's cousin, who would go on to win the Nobel Prize in Chemistry. Today some of Boehringer Ingelheim's most well-known drugs treat COPD, anti-coagulation and type 2 diabetes. Erich along with 14 members of the family own equal parts of the company.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Erich von Baumbach’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Erich von Baumbach’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $6.6B
(May 4, 2026)
© Iconic Billionaires